Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04633239
Title Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer
Recruitment Suspended
Gender female
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

ovary epithelial cancer

Therapies

Abemaciclib + Olaparib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.